The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
November 25th 2024
Acoramidis is a novel, highly potent transthyretin stabilizer.
Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, discussed how liver-directed therapy is approached in the treatment of liver metastases in patients with gastrointestinal neuroendocrine tumors.
Watch
How Health Systems Can Address the National Blood Shortage, Increase Blood Donations
November 8th 2021Jennifer Andrews, MD, pediatric hematologist-oncologist at Vanderbilt University Medical Center and medical director of Vanderbilt University Medical Center’s blood bank, discusses what health systems can do to address the national blood shortage and increase blood donations.
Watch
How Specialty Pharmacies Can Support Palliative Care During Cancer Treatment
November 8th 2021Jameshia Below, PharmD, an assistant professor of pharmacy practice at the University of Louisiana Monroe College of Pharmacy, explains how palliative care can support the cancer treatment process, and how specialty pharmacies can support this type of care.
Watch
Microbiome Therapeutic Demonstrates Reduction of C. Difficile Recurrence
November 8th 2021SER-109, an investigational, oral, biologically-sourced microbiome therapeutic designed to reduce recurrence of C. difficile infection (CDI), demonstrated a 31.1% absolute reduction in the rate of CDI recurrence over 12 weeks compared to placebo
Read More
Expert: MDMA Is Very Likely to Be FDA-Approved for PTSD by the End of 2023
November 8th 2021Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, discusses common themes or key points being raised in the field of psychedelic medicine at recent conferences.
Watch
Nonsteroidal Mineralcorticoid Receptor Antagonists in Managing Hyperkalemia
November 5th 2021Dr. Cary Boyd-Shiwarski explains how nonsteroidal mineralcorticoid receptor antagonists and novel potassium-binding agents alter the management of hyperkalemia and approaching potassium handling in chronic kidney disease.
Watch
FDA Accepts BLA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma
November 3rd 2021The FDA also granted Priority Review designation for the toripalimab BLA and set a Prescription Drug User Fee Act action date for April 2022; however, the FDA is not currently planning to hold an advisory committee meeting to discuss the application.
Read More